Ionis Pharmaceuticals Inc at H C Wainwright Hereditary Angioedema (HAE) Conference (Virtual) Transcript
Okay. Welcome back, everybody. For those of you just logging in, I hope it's not your first discussion. We've had a lot of great presentations today. I'm Joe Pantginis, Director of Research as well as Managing Director and Senior Analyst here at H.C. Wainwright. Welcome back to our HAE conference, a lot of great discussions like I said.
Very happy to have with us Ionis Pharmaceuticals to present next as part of our fireside chat. Presenting for the company is Dr. Kenneth Newman. He's the Vice President of Clinical Development, Ionis. Dr. Newman is a physician, who trained at Duke, Johns Hopkins and the NIH. He was on the faculty at the National Jewish Center for Immunology and Respiratory Disease in Denver and at the University of Cincinnati before joining the pharmaceutical industry in 1998. Dr. Newman has over 20 years of experience in developing new drugs and is responsible at Ionis for the clinical development of all pulmonary and immunological compounds, and he joined
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
